Reference:
- Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin
Summary, Number 222. Obstet Gynecol 2020; 135:1492.
- Yang, Y; Le Ray, I; Zhu, J; et al.Preeclampsia Prevalence, Risk
Factors, and Pregnancy Outcomes in Sweden and China.[J].JAMA Netw
Open.2021,4(5):e218401.
- Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia:
pathophysiology and clinical implications. BMJ. 2019;366: l2381.
- Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH,
Verlohren S. From first-trimester screening to risk stratification of
evolving pre-eclampsia in second and third trimesters of pregnancy:
comprehensive approach. Ultrasound Obstet Gynecol. 2020
Jan;55(1):5-12.
- Verlohren S, Herraiz I, Lapaire O, et al. New gestational
phase–specific cutoff values for the use of the soluble fms-like
tyrosine kinase-1/placental growth factor ratio as a diagnostic test
for preeclampsia. Hypertension. 2014 Feb;63(2):346-52.
- Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the
sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med.
2016;374(1):13-22.
- Bian X, Biswas A, Huang X, et al. Short-term Prediction of Adverse
Outcomes Using the sFlt-1 (Soluble sms-Like Tyrosin Kinase 1)/PlGF
(Placental Growth Factor) Ratio in Asian Women With Suspected
Preeclampsia. Hypertension. 2019, 74(1): 164-172.
- Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of
Pregnancy: ISSHP Classification, Diagnosis, and Management
Recommendations for International Practice. Hypertension 2018; 72:24.
- Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre‐Eclampsia:
Pathogenesis, Novel Diagnostics and Therapies. Nat Rev Nephrol. 2019,
15, 275–289.
- Sisti G, Colombi I. New blood pressure cut off for preeclampsia
definition: 130/80 mmHg. Eur J Obstet Gynecol Reprod Biol 2019;
240:322.
[11]Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM,
Shennan AH, Chappell LC; PARROT trial group. Placental growth factor
testing to assess women with suspected pre-eclampsia: a multicentre,
pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet.
2019 May 4;393(10183):1807-1818.
[12]Dreige, LA; Perschel, FH; Stütz, N; et al.Prediction of
Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble
fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in
the Clinical Routine: A Real-World
Study.[J].Hypertension.2021,77(2):461-471.
[13]Ng QJ, Han JY, Saffari SE, et al. Longitudinal circulating
placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1
(sFlt-1) concentrations during pregnancy in Asian women: a prospective
cohort study. BMJ Open. 2019;9(5):e028321.
[14]Semir Kose, Gamze Tuna, Gülnar Nuriyeva, Sabahattin Altunyurt,
Gü Hüray Islekel, Omer Erbil Doğan. A prospective cohort study on the
prediction of the diagnosis-to-delivery time in preeclamptic
pregnancies: should the sFlt-1/PlGF ratio be added to routine
evaluations? [J] Arch Gynecol Obstet. 2018;298(5):911-920.
[15]Luke B, Brown MB, Eisenberg ML, et al. In vitro fertilization
and risk for hypertensive disorders of pregnancy: associations with
treatment parameters. Am J Obstet Gynecol 2020; 222:350.e1.
[16]Perales A, Delgado JL, de la Calle M, et al. sFlt-1/PlGF for
prediction of early-onset pre-eclampsia: STEPS (Study of Early
Pre-eclampsia in Spain). Ultrasound Obstet Gynecol.
2017;50(3):373-382.
[17]Suzuki H, Hirashima C, Nagayama S, Takahashi K, Yamamoto T,
Matsubara S, Ohkuchi A. Increased serum levels of sFlt-1/PlGF ratio in
preeclamptic women with onset at <32 weeks compared with
≥32 weeks. Pregnancy Hypertens. 2018 Apr;12:96-103.
[18]Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio
in different types of hypertensive pregnancy disorders and its
prognostic potential in preeclamptic patients. Am J Obstet Gynecol.
2012;206(1):58.e1-58.e588.
[19]Boriboonhirunsarn D, Pradyachaipimol A, Viriyapak B. Incidence
of superimposed preeclampsia among pregnant Asian women with chronic
hypertension. Hypertens Pregnancy. 2017;36(2):226-231.
[20]Verlohren,S;Dröge,LA;The diagnostic value of angiogenic and
antiangiogenic factors in differential diagnosis of preeclampsia. Am J
Obstet Gynecol.2020 Sep 28.